GoodRx Holdings (GDRX) Total Non-Current Liabilities (2019 - 2026)

GoodRx Holdings' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 119.33% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (up 119.33% YoY), while the FY2025 annual figure was $779.1 million, up 18.64% from the prior year.
• Total Non-Current Liabilities came in at $1.4 billion for Q1 2026 at GoodRx Holdings, up from $779.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q1 2026 to a low of $634.0 million in Q1 2025.
• A 5-year average of $786.8 million and a median of $776.0 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities retreated 22.16% in 2025 and soared 119.33% in 2026, its largest moves.
• GoodRx Holdings' Total Non-Current Liabilities stood at $782.2 million in 2022, then increased by 4.66% to $818.7 million in 2023, then decreased by 19.79% to $656.7 million in 2024, then advanced by 18.64% to $779.1 million in 2025, then jumped by 78.49% to $1.4 billion in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.4 billion, $779.1 million, and $717.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison